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The S100 proteins are a unique class of EF-hand Ca2+ binding proteins distributed in a cell-specific, tissue-specific, and cell 
cycle-specific manner in humans and other vertebrates. These proteins are distinguished by their distinctive homodimeric 
structure, both intracellular and extracellular functions, and the ability to bind transition metals at the dimer interface. Here we 
summarize current knowledge of S100 protein binding of Zn2+, Cu2+ and Mn2+ ions, focusing on binding affinities, conforma-
tional changes that arise from metal binding, and the roles of transition metal binding in S100 protein function. 
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S100 proteins are an important class of EF-hand calcium 
binding proteins distinguished by unique dimeric structures 
and functions both inside and outside cells (Donato, 2003; 
Donato et al., 2013; Nelson and Chazin, 1998; Potts et al., 
1995; Zackular et al., 2015). Their intracellular functions 
are primarily regulatory in nature, mediated by interactions 
with target proteins involved in a range of processes in-
cluding proliferation, differentiation, and inflammation. 
S100 proteins are also released or secreted from cells, where 
they activate a variety of cell surface receptors in both an 
autocrine and a paracrine manner. Several S100 proteins 
serve as damage-associated molecular pattern recognition 
factors (DAMPS) in the adaptive and innate immune sys-
tems (Donato et al., 2013), and are known to be recruited to 
sites of inflammation (Striz and Trebichavsky, 2004). The 
S100A8/S100A9 heterodimer (termed calprotectin or CP) is 
the most-well studied of the S100 proteins in the immune 
response; it has been shown to function in the response to a 
range of microbial pathogens via a mechanism termed “nu-
tritional immunity”, inhibiting growth by sequestering nu-
trient transition metals Zn2+ and Mn2+ (Zackular et al., 
2015). The binding of transition metals by S100 proteins 
was first characterized over 30 years ago (Baudier et al., 
1982, 1984). With a specific functional role for transition 
metal binding by S100 proteins now emerging, it is an ap-
propriate time to review the field. In this monograph, we 
will focus on the wide range of affinities for these ions, the 
structural consequences of transition metal binding, and 
how transition metal binding modulates function.  
S100 proteins were first identified over five decades ago 
from bovine brain and are named on the basis of their solu-
bility in 100% ammonium sulfate (Moore, 1965). To date, 
there are 25 members in the human proteome and homo-
logues have only been identified only in vertebrates, sug-
gesting that they are “evolutionary newcomers” (Schaub 
and Heizmann, 2008). Unlike other EF-hand proteins, they 
exhibit cell-type, tissue-specific, and cell cycle-dependent 
expression along with differential gene regulation (Schäfer 
and Heizmann, 1996). S100 proteins are involved in a wide 
range of cellular functions including intracellular calcium 
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buffering, modulation of enzyme activities, energy metabo-
lism, and regulation of cell growth, cytoskeleton develop-
ment and differentiation (Schaub and Heizmann, 2008). 
While EF-hand proteins appear to have evolved to transduce 
intracellular Ca2+ signals, S100 proteins have the unique 
ability to also function in the extracellular milieu. Some 
S100 proteins play essential roles in signaling and secretion 
of ligands for receptor binding (Donato et al., 2013), modu-
lated in certain cases by post-translational modifications and 
transition metal binding (Moroz et al., 2009a; van Dieck et 
al., 2009). S100 proteins are also part of the innate immune 
response to bacterial pathogens (Zackular et al., 2015). In 
the clinic S100 proteins serve as biomarkers for cardiomy-
opathy (S100A1), psoriasis (S100A7), chronic inflamma-
tion disorders and inflammatory bowel disease 
(S100A8/A9), and several cancers (S100A2/A4/A6) 
(Heizmann et al., 2002; Schäfer and Heizmann, 1996). 
S100 PROTEIN STRUCTURE AND 
BIOCHEMISTRY 
The fundamental organization for all EF-hand Ca2+ binding 
proteins is a four-helix bundle domain containing a pair of 
helix-loop-helix EF-hand motifs (Figure 1). S100 proteins, 
the largest subgroup within the EF-hand superfamily, are 
comprised of an S100-specific N-terminal EF-hand with a 
14-residue Ca2+ binding loop, and a C-terminal EF-hand 
with a canonical 12-residue Ca2+ binding loop (Bunick et 
al., 2004). They are also distinguished from other EF-hand 
proteins (e.g. calmodulin) by obligate formation of dimers 
(Figure 1) (Potts et al., 1996); all function as dimers or 
higher order oligomers except for calbindin D9k (S100G), 
which is a shortened, ancestral member of the sub-family 
that lacks the ability to dimerize. Higher order oligomeriza-
tion of S100 proteins is non-covalent and can be promoted 
by low affinity metal binding sites at the exterior surface of 
the dimer. Both Ca2+ and transition metals (particularly 
Zn2+) have been shown to stimulate oligomerization in vitro, 
and crystal structures have revealed a range of oligomeric 
states. However, the relevance of oligomerization of S100 
proteins in vivo remains controversial except in situations 
where protein and metal concentrations are sufficiently high 
to match the conditions of the in vitro experiments. That 
stated, the high (millimolar) concentration of Ca2+ in the 
extracellular space implies that those S100 proteins whose 
oligomerization is promoted by Ca2+ may exist in higher 
order oligomeric states. 
Like other EF-hand proteins, S100 proteins respond to 
Ca2+ signals by undergoing conformational changes upon 
ion binding, although the conformational changes are more 
modest relative to canonical EF-hand Ca2+ sensor proteins 
such as calmodulin (Nelson and Chazin, 1998; Nelson et al., 
2002). Despite large variations in amino acid sequence 
(between 20% and 60% identity), the Ca2+-induced confor-
mational change in all S100 proteins involves a significant 
shift in the orientation of Helix III (Figure 2) (Maler et al., 
2002). Like other EF-hand Ca2+ sensors, this conformational 
change results in exposure of a hydrophobic patch that 
serves as the key factor driving binding of targets. Although 
they have very similar structural architectures, S100 pro-
teins interact with a diverse set of cellular targets. This var-
iability is accomplished by the fine-tuning within the target 
binding site of each S100 protein (Bhattacharya et al., 
2004), in combination with their distinct cell-type, tis-
sue-specific, and cell cycle-dependent expression. Current 
understanding of the cooperativity of Ca2+ binding and the 
structural rearrangements induced by Ca2+ binding have 
been reviewed in more detail elsewhere (Chazin, 2007; 
Ikura, 1996; Nelson and Chazin, 1998). Here we will focus 
on the unique ability of S100 proteins to bind transition 
metals in binding sites distinct from their Ca2+ binding sites 
(Heizmann and Cox, 1998), and the corresponding effects 
on structure, function and biochemical properties. 
BINDING OF ZINC  
The first report of Zn2+ binding to an S100 protein (S100B) 
was over thirty years ago (Baudier et al., 1984). Since that 
time binding of Zn2+ has been reported for S100A1, 
S100A2, S100A3, S100A5, S100A6, S100A7, S100A8/A9, 
S100A12, S100A16 and S100B (Table 1). Zn2+ binding 
S100 proteins can be classified into two categories: His-rich 
and Cys-rich. Sequence alignments, spectroscopic analysis, 
site-directed mutagenesis and high-resolution structures 
 
 
Figure 1  Structural features of S100 proteins. Ribbon diagrams of (A) an EF-hand motif, (B) an EF-hand domain, (C) the integration of two EF-hand do-
mains into an S100 dimer, and (D) the alternate arrangement of two EF-hand domains in a prototypical EF-hand Ca2+ signal modulator. S100A12 was se-
lected as the representative member of the S100 proteins and panels A, B and C were created using the Ca2+-loaded protein (PDB entry 1E8A). Panel D was 
created using Ca2+-loaded calmodulin (PDB entry 1CLL). The compact nature of the S100 homodimer relative to calmodulin implies a fundamentally dif-
ferent structural mechanism for transduction of Ca2+ signals. 
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S100A1 <Kd (S100B) 
Trp fluorescence (Baudier, et al., 1986) 
  
S100A2 49 nmol L1 (Ca) 
25 nmol L1 (+Ca) 
Competition with Zn chelator (Koch et al., 2007) 
  
S100A3 4 nmol L1 (Ca) 
Competition with Zn chelator (Fritz, et al., 2002) 
  
S100A5 1–3 µmol L1 (Ca) 
Equilibrium gel filtration (Schäfer, et al., 2000) 
 5 µmol L1 (Ca) 
Equilibrium gel filtration (Schäfer et 
al., 2000) 
S100A6 100 nmol L1 (+Ca) 
Fluorescence spectroscopy (Kordowska, et al., 1988) 
  
S100A7 100 µmol L1 (Ca) 
Equilibrium dialysis ( Vorum, et al., 1996) 
  
S100A8/A9 3 nmol L1 (+Ca) Site1 (Mn/Zn) 
8 nmol L1 (+Ca) Site2 (Zn only) 
ITC (isothermal titration calorimetry) (Damo, et al., 2013) 
Kd1≤10 pmol L
1 (excess Ca) 
Kd2≤240 pmol L
1 (excess Ca) 
Fluorescent competition (Brophy, et al., 2012) 
6 nmol L1 (+Ca) Site1 (Mn/Zn) 
ITC (Damo, et al., 2013) 
 
Kd1=200 nmol L
1 (excess Ca) 
Kd2=20 µmol L
1 (excess Ca) 
EPR titrations ( Haydenet al., 2013) 
 
S100A12 2 and 100 µmol L1 (Ca) 
Fluorescence spectroscopy (Moroz, et al., 2009) 
  
 
S100A13   12 and 55 µmol L1 (Ca) 
62 and 120 µmol L1 (+Ca) 
ITC (Sivaraja, et al., 2006) 
S100A16 ~ 25 µmol L1 (Ca) 
Equilibrium gel filtration (Sturchler et al., 2006) 
  
S100B 94 nmol L1 (+Ca) 
ITC (Wilder et al., 2003) 
71 µmol L1 (Ca) 
55.9 μmol L1 (+Ca) 
EPR and NMR ( Rustandi et al., 1988) 
Average 0.46 µmol L1 (Ca) 
Equilibrium filtration (Nishikawa et 
al., 1997) 
 
revealed a conserved binding motif for the proteins with 
His-rich sites (S100A6, S100A7, S100A8/A9, S100A12, 
S100A15, S100B), with 4 His residues, or 3 His and 1 Asp 
residues, at the dimer interface (Figure 3). The first 
Zn2+-bound structure was determined for S100A7 
(Brodersen et al., 1999), and several additional Zn2+-bound 
structures from the His-rich group have been reported since. 
Since the proteins are dimers, each protein binds two Zn2+ at 
the two symmetrically disposed sites (Figure 2). 
The S100 proteins capable of binding Zn2+ ions have af-
finities ranging from Kd=4 nmol L
1 (S100A3) to 100 µmol 
L1 (S100A7) (Table 1). Direct comparisons among the re-
ported affinities are not straightforward because the meth-
ods used and experimental conditions vary significantly. 
Importantly, although the majority of the Kd values fall 
within the µmol L1 range, Zn2+ concentrations inside and 
outside cells are low (e.g. 2–10 nmol L1 in the cytoplasm). 
Hence, the biological relevance of the binding of Zn2+ has 
yet to be established for most S100 proteins. Another sig-
nificant factor in correlating in vitro measurements to func-
tional context is the energetic coupling of interactions with 
metal co-factors and targets. This issue is well recognized 
for EF-hand proteins in the case of the substantial differ-
ences in Ca2+ affinity measured in the absence and presence 
of target proteins. Thus, an interplay between Zn2+ and Ca2+ 
binding to S100 proteins is expected.  In fact, Zn2+ binding 
has been reported to raise the Ca2+ affinity of S100B by a 
factor of 10 and of S10012 by ~1500 fold (Dell’Angelica et 
al., 1994; Moroz et al., 2011), to lower the Ca2+ affinity of 
S100A2 (Koch et al., 2007), and to have no effect on 
S100A5 (Schäfer et al., 2000).  
The effects of Zn2+ binding on the structure of S100 pro-
teins are in general rather modest. The basic dimeric archi-
tecture observed for the apo and Ca2+-loaded states is re-
tained and overall the structures are very similar (all C 
RMSDs (root-mean-square deviations)<1.0 Å) (Figure 2A). 
The structural changes induced by the binding of Ca2+ are 
substantially larger than the structural changes induced by 
the binding of Zn2+, i.e. Zn2+-bound apo proteins are more 
similar to the apo state than to the Zn2+-bound Ca2+-loaded 
state, and Zn2+-bound Ca2+-loaded proteins are more similar 
to the Ca2+-loaded state than to the Zn2+-bound apo state 
(Figure 2B). Detailed comparative analyses for structural 
differences between all states are possible for S100A7, for 
which structures have been determined in the apo, 
Ca2+-loaded, and Ca2+, Zn2+-loaded states, and for S100A12, 
for which structures have been determined in the apo, 
Ca2+-loaded, Zn2+-loaded, and Ca2+,Cu2+-loaded states. (The 
great similarity of Zn2+ and Cu2+ sites is discussed below in 
“Binding of copper”) As seen in the Zn2+-loaded structures 
of S100A7 and S100A12, two Zn2+ ions are bound at the 
symmetrically disposed sites (Figure 4), coordinated by 
three His N2 atoms (His17, His86, His90) and an aspartate 
side chain (Asp24) (Figure 4B) (Brodersen et al., 1999;
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2+)2, states. B, Comparison of single sub-units to emphasize the differences in the packing of Helix III in different states. This 
reveals that the consequences of binding Ca2+ are much greater than those of binding transition metals. Images generated in pymol (DeLano, 2002) using 
coordinates deposited in the PDB for apo (2WCF), (Ca2+)4 (1E8A), (Zn




Figure 3  Alignments of S100 proteins containing transition metal binding sites. Structure based sequence alignment of S100 proteins from the His-rich 
(upper panel) and Cys-rich (lower panel) categories. Conserved residues in His-rich sites are highlighted with teal background, and those in Cys-rich sites in 
red background. Note the high degree of conservation in the His-rich proteins compared to the Cys-rich proteins. The alignments were generated using 
PROMALS3D (Pei et al., 2008). 
Leon et al., 2009). In all cases, the primary effect of Zn2+ is 
to alter the orientation of Helix III (Figure 2B). Interesting-
ly, Zn2+-binding results in poor electron density for residues 
62–67 in S100A12, even though these are well defined in 
the structure of the apo state (Moroz et al., 2009a). This led 
to the proposal that flexibility in this loop region may be 
induced by Zn2+, and thereby facilitate the ~1500-fold  
increase in the affinity of S100A12 for Ca2+.  
The binding of Zn2+ has been extensively studied for 
S100B, most notably in conjunction with the p53 tumor 
suppressor protein (Lin et al., 2004). S100B has high affin- 
ity for Zn2+ (Kd ~90 nmol L
1). NMR spectroscopy and site 
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Figure 4  Structural similarity of tetrahedral zinc and copper binding sites in S100 proteins. A, Overlay of the structures of (Ca2+)4, (Zn2+)2-S100A7 (light 
green), (Ca2+)4, (Zn
2+)2-S100B (teal) and (Ca
2+)4, (Cu
2+)2-S100A12 (purple) showing that the transition metal ions are chelated in a similar manner by side 
chains in the same position in the sequence. B, Zoom in on the tetrahedral Zn2+ and Cu2+ sites showing the similar spatial disposition of the 3 His and 1 Asp 
chelating side chains. The Zn2+ and Cu2+ ions are colored gray and orange, respectively. Images generated in pymol (DeLano, 2002) using PDB coordinates 
deposited for (Ca2+)4, (Zn
2+)2-S100A7 (2PSR), (Ca
2+)4, (Zn
2+)2-S100B (3D0Y), and (Ca
2+)4, (Cu
2+)2-S100A12 (1ODB). 
directed mutagenesis indicated that Zn2+ binding occurs in a 
similar manner to other S100 proteins with His-rich transi- 
tion metal binding sites, namely His15/His25 from one 
subunit and His85/His89 from the other subunit. However, 
Zn2+ binding to S100B causes a more pronounced kink in 
Helix IV than in S100A7 and S100A12 (Wilder et al., 
2005). Zn2+ binding has been shown to increase the affinity 
for target peptides over the effect of Ca2+ alone (Wilder et 
al., 2003). Structural coupling of the Zn2+ and target binding 
sites has been found, and this information has been incor-
porated into the design of S100B inhibitors of the interac-
tion with targets such as p53. Co-crystal structures with 
pentamidine, an S100B inhibitor known to bind in the target 
binding site, were determined for both the Ca2+- and Ca2+, 
Zn2+-loaded states (Charpentier et al., 2008; Charpentier et 
al., 2009). These studies motivated the generation of new 
inhibitors engineered to disrupt the Zn2+-binding residues 
and Zn2+-induced conformational changes in S100B 
(Cavalier et al., 2014).  
The role of oligomerization in the function of S100 pro-
teins has been vigorously debated. There is ample evidence 
of Ca2+- and Zn2+-induced oligomerization in vitro includ-
ing a number of crystal structures with high order oli-
gomerization states (Moroz et al., 2002, 2009a; Ostendorp 
et al., 2007) and a mass spectrometry study of Zn2+-induced 
tetramerization of CP (Vogl et al., 2006). However, there is 
very little evidence of the functional significance of oli-
gomerization from experiments in cells; this is an area that 
is in great need of further investigation. A role for oli-
gomerization of S100 proteins is most likely in association 
with the extracellular functions of S100 proteins as activa-
tors of cell surface receptors (Malashkevich et al., 2010; 
Moroz et al., 2009a; Ostendorp et al., 2011, 2007). The 
most well studied of these receptors is receptor for ad-
vanced glycation end products (RAGE), which has been  
shown to bind several S100 proteins at the cell surface and 
elicit an intracellular response via the NF-B signaling 
pathway. A role for Zn2+ in the interaction of S100A7 and 
S100A15 with RAGE has been proposed (Murray et al., 
2012; Wolf et al., 2008).  
The Cys-rich Zn2+ binding S100 proteins (S100A2, 
S100A3, S100A4) are much less studied than the His-rich 
group (Moroz et al., 2011). One challenge is the absence of 
a conserved motif evident from alignment of these proteins 
(Figure 3). The consensus view is that the Cys-rich sites 
coordinate Zn2+ ions with either 4 Cys residues or 3 Cys and 
1 His residue (Moroz et al., 2011). A second challenge is 
that Cys-rich sites will be susceptible to redox reactions that 
disrupt disulfides and modulate Zn2+-binding. Obtaining 
high resolution X-ray data on the Cys-rich Zn2+-binding 
S100 proteins is difficult due to improper folding during in 
vitro bacterial overexpression. In fact, the majority of 
S100A2 and S100A4 structures were determined with Cys 
residues mutated to facilitate protein production. The pro-
tein production obstacle was overcome for S100A3 by pro-
ducing the protein from insect cells, which promotes proper 
disulfide formation and folding (Kizawa et al., 2013a, b). 
Crystallization of S100A3 produced in this manner identi-
fied two disulfide bonds not previously identified. These 
disulfides apparently play a critical structural role, as dis-
ruption of either disulfide significantly affected the Ca2+ 
affinity (Unno et al., 2011). Unfortunately, electron density 
for Zn2+ ions was too weak to formally assign their presence 
in the structure. However, a single Cys-rich Zn2+ site could 
be readily modeled, and Zn2+ binding was proposed to be 
important for folding and formation of the critical disulfide 
bonds in S100A3. Since the majority of analyses in the past 
15 years utilized recombinant protein expressed in E. coli, 
future studies using proteins produced from eukaryotic ex-
pression systems may enhance understanding of Zn2+ bind-
ing to S100 proteins from the Cys-rich group. 
BINDING OF COPPER 
Due to their similar chemical properties, copper is antici-
pated to bind to most zinc binding sites in proteins. It was 
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therefore natural to examine the binding of copper (Cu2+) to 
S100 proteins when Zn2+ binding was first noted for S100B 
(Nishikawa et al., 1997). In that report, four Cu2+ ions were 
identified per S100B dimer with an average dissociation 
constant (Kd) of 0.46 µmol L
1. However, subsequent struc-
ture-based alignments predicted that there are only two high 
affinity sites and that the two others are weak non-specific 
sites (Nishikawa et al., 1997). Ion competition experiments 
demonstrated that the Cu2+ ions could be displaced by Zn2+, 
but not Ca2+. Thus, as expected, the binding of Cu2+ by 
S100 proteins closely resembles binding of Zn2+, with a few 
noticeable exceptions.  
Important insight into binding of Cu2+ by S100 proteins 
was provided by the X-ray crystal structure of Ca2+, 
Cu2+-S100A12 (Moroz et al., 2003). The overall conforma-
tional change induced by the binding of Cu2+ is very small; 
the C RMSD of the Ca2+ versus the Ca2+, Cu2+ state is 0.35 
Å. Interestingly, both the apo and Ca2+, Cu2+-bound states 
have well defined electron density out to Lys90, but 
His87-Lys90 is disordered when only Ca2+ is bound (Moroz 
et al., 2003). The Cu2+ ion is bound in a canonical Cu2+ site 
(3 His residues along with either an oxygen or sulfur con-
taining residue), with coordination by His15 and Asp25 
from one subunit and His85 and His89 from the other subu-
nit, identical to the coordination of Zn2+. In fact, Ca2+, Cu2+ 
and Ca2+, Zn2+ structures are very similar even when com-
paring between different S100 proteins (Figure 4): the C 
RMSD between Ca2+, Cu2+-S100A12 and Ca2+, Zn2+- 
S100A7 is only 0.72 Å, and for Ca2+, Zn2+-S100B only 0.42 
Å (Charpentier et al., 2008). The great similarity in the 
structures of the Cu2+ and Zn2+-loaded protein implies that 
Cu2+ will bind to the Zn2+ sites in other S100 proteins 
(Moroz et al., 2003, 2009b).  
The structural consequences of Cu2+ binding to S100A13 
have been investigated using solution NMR (Arnesano et 
al., 2005). Comparisons between apo, Ca2+-loaded and Ca2+, 
Cu2+-loaded S100A13 revealed Cu2+ causes an additional, 
minor opening of the Helix III-IV interface relative to the 
Ca2+-loaded state. The binding site has several unique char-
acteristics compared to other S100 proteins, including the 
location of the site, as well as the ligand coordination and 
solvent accessibility to the Cu2+ ion. NMR titrations of 
Ca2+-S100A13 with paramagnetic Cu2+ ions were used to 
propose Glu4, Glu8, Glu11, and His48 as the Cu2+-chelating 
side chains. These correlated with electron paramagnetic 
resonance (EPR) studies that assigned the Cu2+ coordination 
as pseudo-tetragonal with nitrogen and oxygen donor atoms. 
An unexpected aspect of their analysis was that the Cu2+ 
ions are completely exposed to solvent, unlike the typical 
transition metal sites that are buried within the S100 pro-
teins (Arnesano et al., 2005). The authors suggested that 
exposure of the metal may help regulate the interaction of 
S100A13 with target proteins, but no data was provided in 
support of this speculation.  
Zn2+ and Cu2+ ions have been proposed to induce con-
formational changes in S100 proteins (e.g. (Vogl et al., 
2006)), although the crystal structures described above and 
shown in Figure 4 reveal these changes are very modest. 
Nevertheless, Cu2+ binding has the potential to alter the 
structure of S100 proteins and therefore oligomerization and 
interactions with target proteins. Although Zn2+ induced 
oligomerization of S100 proteins has been explored in vitro, 
the sole study of the effect of Cu2+ reported no changes in 
oligomerization of the S100A8/S100A9 heterodimer (Vogl 
et al., 2006). The only study of the effect of Cu2+ on recep-
tor binding revealed stimulation of the interaction of 
S100A4 with RAGE (Haase-Kohn et al., 2011). Although 
the dearth of information about the effects of Cu2+ on phys-
ical properties should be addressed, there is even greater 
urgency to establish if Cu2+ binding has any physiological 
role in S100 protein function. 
BINDING OF MANGANESE  
Manganese is an important transition metal in biological 
systems (Sigel and Sigel, 2000). It is a critical component in 
certain enzymatic processes (e.g. phosphorylation) and in 
the oxidative stress response. Recently, manganese regula-
tion has been recognized for its essential role in contributing 
to the virulence of pathogenic organisms (reviewed in 
(Zackular et al., 2015)), with an explicit role played by the 
S100A8/S100A9 heterodimer, calprotectin (CP). As will be 
summarized below, high affinity binding of Mn2+ to S100 
proteins is unique to CP. 
All pathogenic organisms require essential nutrients from 
the host to survive and proliferate, including transition met-
als. A mechanism termed nutritional immunity, which in-
volves sequestering the essential nutrients from the patho-
gen, is used by the host to fight infection. A role for transi-
tion metals besides Fe in nutritional immunity was first 
discovered when inductively coupled plasma mass spec-
trometry (ICP-MS) analysis showed that there are distinct 
differences in the transition metal content in and around 
tissues infected with Staphylococcus aureus (Corbin et al., 
2008). In particular, staphylococcal abscesses were found to 
be devoid of Zn2+ and Mn2+ ions. Proteomic imaging of the 
tissue revealed high concentrations of the S100A8 and 
S100A9 CP subunits surrounding the sites of infection. 
Subsequent work confirmed that CP, which is present in 
very large abundance in certain innate immune cells such as 
neutrophils, plays a critical role in the innate immune re-
sponse to pathogens, functioning via the nutritional immun-
ity mechanism through the high affinity binding and se-
questration of Zn2+ and Mn2+ (Corbin et al., 2008; Zackular 
et al., 2015). Subsequent studies using CP knockout mice 
have demonstrated that CP inhibits growth from other 
pathogenic organisms, including Acinetobacter baumannii, 
Candida albicans, Aspergillus fumigatus and Helicobacter 
pylori (Clark et al., 2016; Gaddy et al., 2014; Hood et al., 
2012; Kehl-Fie et al., 2011, 2013). 
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Based on the available information on the binding of 
Zn2+ to S100 proteins, it was assumed that Mn2+ bound to 
similar sites and completed its coordination shell with wa-
ters. Importantly, early studies showed that CP bound 2 
equivalents of Zn2+ ions, but only one equivalent of Mn2+. 
This was confirmed by site-directed mutagenesis studies 
that revealed Mn2+ binds to the 4-His site (His17 and His27 
from S100A8, His91 and His95 from S100A9) (Kehl-Fie et 
al., 2011). Site directed mutagenesis experiments also 
showed that two His residues in the S100A9 C-terminal tail 
(His103, His105) are required for high affinity Mn2+ bind-
ing (Brophy et al., 2013; Damo et al., 2013). As noted 
above, there is energetic coupling of transition metal bind-
ing and Ca2+ binding; the Mn2+ affinity of CP under limited 
Ca2+ availability (Kd>550 nmol L
1) is weaker than in the 
presence of Ca2+ (Kd=194 nmol L
1) (Brophy and Nolan, 
2015; Damo et al., 2013). The origin of this allosteric effect 
has yet to be established, although it is conceivable that 
binding of Ca2+ results in reorganization of the structure 
and/or dynamics of key side chains to better facilitate Mn2+ 
binding. Notably, the only known function of transition 
metal binding for CP is in the extracellular milieu where 
Ca2+ concentrations are very high (in the mmol L1 range) 
and CP’s Ca2+ sites will invariably be filled, so the physio-
logical relevance of the difference in Mn2+ affinities in the 
absence and presence of Ca2+ remains uncertain. 
The critical step forward in characterizing the binding of 
Mn2+ to CP was the determination of the crystal structure of 
(Ca2+)4, Mn
2+-CP (Brophy et al., 2013; Damo et al., 2013; 
Gagnon et al., 2015) (Figure 5). Comparison with the 
(Ca2+)4-CP structure (Korndorfer et al., 2007) revealed there 
are no large conformational changes. The C RMSD be-
tween the two structures is 0.29 Å for the S100A8 subunit 
and 0.24 Å for the S100A9 subunit. Previous crystal struc-
tures of CP were disordered beyond His95 in the C-terminal 
tail; only with the addition of Mn2+ ions in the crystal struc-
ture was electron density out to Gly112 well defined. This 
correlates with the direct observation of chelation of the 
Mn2+ ion by the His103 and His105 side chains. Typically, 
Mn2+ is coordinated by 5 or 6 ligands. The Mn2+ site in CP 
is the only example of 6-His octahedral coordination of 
Mn2+ in the Protein DataBank (PDB). CP is the only mem-
ber of the S100 protein group that is capable of high affinity 
binding of Mn2+ (Brophy et al., 2013; Brophy and Nolan, 
2015; Damo et al., 2013); the crystal structure shows that 
this is due to the unique combination of the 4-His transition 
metal binding site at the heterodimer interface (Figure 5) 
and the His-rich C-terminal tail that is unique to S100A9. 
BINDING OF OTHER TRANSITION METALS 
Robust Zn2+ binding at the dimerization interface led to 
studies of the ability of S100 proteins to bind other first-row 
transition metals besides Mn2+ and Cu2+, but no significant 
affinities were observed (Fritz et al., 1998). A recent study 
reports that CP is capable of sequestering ferrous (Fe2+) iron 
from pathogenic growth media, in parallel to sequestration 
of Mn2+ and Zn2+ (Nakashige et al., 2015). However, the 
relevance of ferrous iron to the host-pathogen interaction 
has not been firmly established, and existing in vivo data do 
not support a role for CP in the sequestration of iron as a 
defense strategy against infection (Corbin et al., 2008; 
Damo et al., 2013). Sub-picomolar affinity for Fe2+ was 
reported, with coordination via an uncommon 6-His coor-
dination assigned based on Mössbauer spectroscopy 
(Nakashige et al., 2015) that presumably corresponds to the 
unique Mn2+ binding site in CP. If such very high CP affin-
ity for Fe2+ CP is validated, a role for CP-dependent Fe2+ 
sequestration during infection will need to be investigated.  
 
 
Figure 5  Three-dimensional structure of calprotectin highlighting the unique manganese binding site. The S100A8 subunit is colored blue, the S100A9 
subunit gold, and the Mn2+ ion purple. An additional low occupancy Mn2+ ion is shown in gray. Images generated in pymol (DeLano, 2002) using coordi-
nates deposited in the PDB for (Ca2+)4, (Mn
2+)-CP (4GGF).  
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CONCLUDING REMARKS  
The ability of S100 proteins to bind transition metals at sites 
separate from their Ca2+ binding sites highlights the com-
plexities of their biochemical actions and the everchanging 
environments within and outside cells. Structural analyses 
have identified specific conformational changes induced by 
Ca2+ and transition metals. However, information is urgent-
ly needed to understand if and how transition metals modu-
late S100 protein interactions with their targets. Questions 
regarding oligomerization state and whether transition metal 
binding is needed for signaling to occur also need to be ad-
dressed. Substantial evidence for S100 proteins in human 
disease suggests there is significant potential in pursuing 
S100 proteins as therapeutic targets and motivates ongoing 
efforts in multiple laboratories to develop S100 pro-
tein-specific inhibitors.  
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